NCT00837148 2015-11-20Sorafenib and Dacarbazine in Soft Tissue SarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed37 enrolled 6 charts
NCT00245102 2014-05-23Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent SarcomaNational Cancer Institute (NCI)Phase 2 Completed147 enrolled 13 charts